Biocon shares are expected to be in focus on Tuesday after the company announced regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for its diabetes drug Liraglutide in ...
Accelerated drug development and approval pathways, designed to expedite the delivery of essential medicines for patients with serious and rare diseases, have been successfully implemented in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback